Other Q3 2019 Sales in Other were down considerably from the third quarter of 2018, mainly due to lower volumes and prices in commodity trading. This was partly offset by portfolio effects attributable to the remaining activities of the paper and water chemicals business, which have been reported under Other since February 2019 following the divestiture. Income from operations (EBIT) before special items was considerably below the figure for the prior-year quarter. This was largely attributable to valuation effects for our long-term incentive program. In the third quarter of 2019, EBIT included special income from the sale of BASF’s share of the Klybeck site in Basel, Switzerland. The income after taxes of Wintershall Dea, which is accounted for using the equity method, is included in other businesses. Wintershall Dea’s average daily production in the third quarter was on a level with the months prior. Earnings were reduced by the decline in oil and gas prices. Additional depreciation and amortization from the fair value measurement of Wintershall Dea resulted in a slightly negative earnings contribution to the BASF Group’s EBIT in the third quarter. (XLS:) Download Financial data – Other (Million €) Q3 January–September 2019 2018 +/– 2019 2018 +/– a Amortization of intangible assets and depreciation of property, plant and equipment (including impairments and reversals of impairments) b Contains assets of businesses recognized under Other as well as reconciliation to assets of the BASF Group including the disposal group for the oil and gas business. c Additions to intangible assets and property, plant and equipment Sales 697 845 (18%) 2,141 2,108 2% Income from operations before depreciation, amortization and special items (126) (55) . (494) (198) . Income from operations before depreciation and amortization (EBITDA) 202 (71) . (389) (242) (61%) Depreciation and amortizationa 33 29 14% 133 92 45% Income from operations (EBIT) 169 (100) . (522) (334) (56%) Special items 331 (18) . 104 (43) . EBIT before special items (162) (82) (98%) (626) (291) . of which Costs for cross-divisional corporate research (92) (96) 4% (290) (266) (9%) Costs of corporate headquarters (57) (64) 11% (181) (183) 1% Other businesses 61 18 239% 111 28 296% Foreign currency results, hedging and other measurement effects (15) 31 . (53) 240 . Miscellaneous income and expenses (59) 29 . (213) (110) (94%) Assets (September 30)b 25,704 24,307 6% 25,704 24,307 6% Investments including acquisitionsc (83) 179 . 31 535 (94%) Research and development expenses 96 97 (1%) 300 267 12% back next